Why the study?
Do elevated levels of NT-proBNP, BNP, and hsCRP predict all-cause mortality in patients with non-dialysis chronic kidney disease?
Do elevated levels of NT-proBNP, BNP, and hsCRP predict all-cause mortality in patients with non-dialysis chronic kidney disease?
NT-proBNP and hsCRP are independent predictors of all-cause mortality in non-dialysis CKD patients, suggesting utility for risk stratification.
No takes yet. Share an insight, caveat, or question.
May enhance mortality risk stratification in non-dialysis CKD; hypothesis-generating for biomarker-guided interventions.
Vickery et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: